A new model that uses machine learning, which is a type of artificial intelligence, may help predict which patients with kidney disease are at especially high risk of developing heart beat irregularities.
Treatment with the rheumatoid arthritis drug tocilizumab, sold as Actemra, reduces the risk for death among hospitalized patients with severe COVID-19 by about 30%, a study published by JAMA Internal Medicine found.
Artificial intelligence (AI) used in machine learning models can predict which patients are at highest risk for severe pain after surgery, and help determine who would most benefit from personalized pain management plans that use non-opioid alternatives, suggests new research being presented at the ANESTHESIOLOGY 2020 annual meeting.
People age 65 years and older account for 40 percent of inpatient operations and one-third of outpatient procedures, and these older patients are more vulnerable to longer hospital stays and other complications after surgery than younger patients.
An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a Phase III clinical trial led by Queen Mary University of London and Barts Cancer Center, the UK.
COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress.
Antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90 percent of recovered COVID-19 patients in Iceland, according to a study published on Tuesday.
People visit the doctor for any number of reasons. An achy back, an annual physical exam or even an especially pesky cold may compel people to book appointments with their physicians. Many such appointments do not require follow-up visits, but those that do may yield information that patients should keep readily available.